• DOI:10.1056/NEJMra1102942
• Corpus ID: 38073643

Ulcerative colitis.

@article{Danese2011UlcerativeC,
  title={Ulcerative colitis.},
  author={Silvio Danese and Claudio Fiocchi},
  journal={The New England journal of medicine},
  year={2011},
  volume={365 18},
  pages={
          1713-25
        }
}

• S. Danese, C. Fiocchi
• Published 2011
• Medicine, Biology
• The New England journal of medicine

 Is medical clearance required? .................................. Possibly (e.g., if the disease is unstable — flare-up — and/or there are active oral lesions). Also, medical clearance may be required if patient/client is being treated with medications associated with immunosuppression +/increased risk of infection (e.g., corticosteroids [e.g., prednisone], azathioprine, 6-mercaptopurine, methotrexate, cyclosporine, sulfasalazine, biologic response modifier drugs [e.g., anti-tumour necrosis factor drugs — anti-TNFs — such as infliximab, adalimumab, certoluzimab, and golimumab, as well as monoclonal antibody drugs such as vedoluzimab], JAK inhibitors [e.g., tofacitinib], etc.).